Immune Design Obtains $32,000,000 Series B Funding Round

  • Feed Type
  • Date
    7/26/2010
  • Company Name
    Immune Design
  • Mailing Address
    1124 Columbia Street Seattle, WA 98104
  • Company Description
    One of the greatest impacts on human health can be achieved by regulating the activity of the immune system. Recent advances in the field of molecular immunology have created new ways to treat infectious disease, cancer, allergy and autoimmunity. We are using this knowledge to discover and develop therapeutics that will protect and save lives world-wide.
  • Website
    http://www.immunedesign.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The closing of the Series B provides resources for accelerating IDC’s lead candidates through clinical studies and further expanding development of new vaccines and therapeutics.
  • M&A Terms
  • Venture Investor
    ProQuest Investments
  • Venture Investor
    The Column Group
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Alta Partners

Trending on Xconomy